Study of Readmission to Intensive Care Unit After Cardiac Surgery in Heart Hospital of Assiut University : Risk Factors .Reasons and Early Out Come

NCT07083297 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2025-07-24

No results posted yet for this study

Summary

Cardiac Surgery is any surgical procedure applied to heart and its connected vessels especially thoracic aorta; representing a treatment option for significant cardiac diseases . As cardiovascular (CVS) diseases is the first leading cause of death worldwide accounting for approximately18 million deaths annually especially in low and middle income countries , medical and surgical treatments are of importance in quality of life of cardiac patient.

Most common causes for cardiac surgery are Coranary artery disease, valvular disease as mitral stenosis or mitral regurgitation, congenital heart diseases. Currently cardiac surgery can provide an advanced treatment for cardiac arrhythmias.

In case of cardiovascular surgery, patient is admitted in Intensive Care Unit (ICU) postoperatively until being stable then discharged. In some cases the patient's state is indicating to be readmitted in ICU, a condition that's required long hospitzation, costs and so, a burden on health services and patient's family.

For controlling this phenomenon; i.e. readmission in ICU, a lot researches were conducted to clarify the leading factors and the outcome in readmitted patients. Preoperative risk factors as renal failure, arrhythmias, chronic obstructive pulmonary disease (COPD) are common noticed factors for readmission of previous heart surgery patient. Also, readmitted patients may have poor clinical outcomes as morbidity and mortality.

In this study we aim to screen for preceding risk factors and report precipitating early events occurring in readmission in ICU.

Conditions

  • Cardiac Surgery

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2026-08-01
Completion
2026-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07083297 on ClinicalTrials.gov